Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

José M Pérez de la Lastra; Uttpal Anand; Sergio González-Acosta; Manuel R López; Abhijit Dey; Elza Bontempi; Antonio Morales delaNuez

doi:10.3389/fimmu.2024.1365827

Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

Front Immunol. 2024 Jan 26:15:1365827. doi: 10.3389/fimmu.2024.1365827. eCollection 2024.

Authors

José M Pérez de la Lastra^#¹, Uttpal Anand^#², Sergio González-Acosta¹, Manuel R López¹, Abhijit Dey³, Elza Bontempi⁴, Antonio Morales delaNuez¹

Affiliations

¹ Biotechnology of Macromolecules, Instituto de Productos Naturales y Agrobiología, IPNA (CSIC), San Cristóbal de la Laguna, Spain.
² CytoGene Research & Development LLP, Barabanki, Uttar Pradesh, India.
³ Department of Life Sciences, Presidency University, Kolkata, India.
⁴ National Interuniversity Consortium of Materials Science and Technology (INSTM) and Chemistry for Technologies Laboratory, Department of Mechanical and Industrial Engineering, University of Brescia, Brescia, Italy.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.921483.].

Keywords: SARS-CoV-2; antibiotic discovery; antibiotic resistance; antimicrobial peptides; environmental contamination; global health; one health approach; vaccination.

Publication types

Published Erratum